Skip to content
Home/Companies/Pharma/Tridem Pharma
TP

Tridem Pharma

Pharma·France·Exited 2017·Held 6yr

Tridem Pharma is a pharma company, headquartered in France.

Entry
2011
Hold
6yr
Exit
2017
Est. EV
–

Who owns Tridem Pharma?

Tridem Pharma was owned by Paluel-Marmont Capital through Paluel-Marmont Capital Fund (2010 vintage) from 2011 to 2017, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-16

Paluel-Marmont Capital
Investor
Paluel-Marmont Capital
Paluel-Marmont Capital Fund · 2010 · Growth

Key facts

HQFrance
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2017

More from Paluel-Marmont Capital Fund

Other portfolio companies in the same fund.

TapNation
Active
TMTFrance· 2023
Snetor
Active
IndustrialsFrance· 2020
Quadrilatere
Active
Business ServicesFrance· 2019
Sogetrel
Exited 2021
TMTFrance· 2018
to
Anaveo
Exited 2016
Business ServicesFrance· 2013
to
Avidom
Exited 2016
HealthcareFrance· 2012
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
cormeo
Active
Bertelsmann InvestmentsGermany· 2025
Crossject
Active
VATEL CAPITALFrance· 2025
Data refreshed weekly · Sourced from public filings